Hello, Fool! | Login | Signup | My Fool
Oct 7, 2008 1:58 AM ET | Feedback | Site Changes | Help
The Company is publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs.
View Ticker Page (GPCB)
Results 1 - 9 of 9 : 1
Recs
tr4sh80 (21.86) Submitted: 7/31/07 5:40 PM : Start Price: $15.19 GPCB Score: -65.55
Looks like they've got a great new cancer treatment ready to go. Was smart of them to withdraw accelerated request for FDA approval pending more result information. Better safe than sorry, and it will give them time to build a better case for FDA app...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
fOOLSONPARADE (99.06) Submitted: 3/02/07 11:19 PM : Start Price: $25.16 GPCB Score: 71.95
I seem to be good a buying stocks when they begin to fall so I now have used my "ability" for shorting sotcks. So far it has paid off in my real portfolio. Here is one more that looks like the only elevator button that works is DO...
albertvny (24.41) Submitted: 6/25/07 5:22 PM : Start Price: $26.10 GPCB Score: -65.88
has satraplatin coming up for fda approval. all trial phases and advisory panels point to a successful approval. will market drug in europe, and has just signed an agreement with a japanese company to market the product in the far east.
ceoofwhoopass (75.56) Submitted: 2/01/07 3:06 PM : Start Price: $29.17 GPCB Score: -69.01
the big ibanks say so. i like the industry
GunnarVagotis (85.89) Submitted: 9/05/07 2:48 PM : Start Price: $13.00 GPCB Score: 63.38
It's true. EVERYONE has cancer, or at least they will. That doesn't mean you should buy this stock (or eat platinum).
utosweet (66.93) Submitted: 2/04/08 6:22 PM : Start Price: $3.95 GPCB Score: 51.72
A very good Bio-tech co. in Europe.Have a lot in the pipe line for anitcancer druges.Keep an eye on this one (mid-summer)
handoverhill (< 20) Submitted: 5/14/08 7:22 AM : Start Price: $4.15 GPCB Score: -50.16
This stock is in the healthcare sector of the market and the industry of biotechnology and drugs. The charts show us again that this stock is being underrated.
lavongduhr (< 20) Submitted: 5/30/08 9:41 AM : Start Price: $4.10 GPCB Score: -50.26
biopharmaceutical company that researches and develops anitcancer drugs. currently in phase I trial for satraplatin, which is a radiation drug that is a therapeutic for non-small lung cancer patients
smith45416 (< 20) Submitted: 6/13/08 8:46 PM : Start Price: $4.21 GPCB Score: -54.11
How many times can you go wrong with a biopharmceutical company
Terms & Conditions
RSS Headlines
Fool UK